Clinical Trials Logo

Post-operative Atrial Fibrillation clinical trials

View clinical trials related to Post-operative Atrial Fibrillation.

Filter by:
  • None
  • Page 1

NCT ID: NCT03525860 Not yet recruiting - Clinical trials for Post-Operative Atrial Fibrillation

Acupuncture Treatment for Patients Who Develop Arrhythmias in the Post-Operative Cardio-Thoracic Setting

Start date: June 2018
Phase: N/A
Study type: Interventional

A feasibility study on the provision of acupuncture treatment in the hospital to 20 patients who have undergone open heart surgery procedures. The acupuncture treatments may begin as early as postoperative Day 2.

NCT ID: NCT02701062 Recruiting - Clinical trials for Post-Operative Atrial Fibrillation

AtriClip® Left Atrial Appendage Exclusion Concomitant to Structural Heart Procedures (ATLAS)

ATLAS
Start date: February 2016
Phase: Phase 4
Study type: Interventional

Patients without a documented history of AF but who present with a CHA2DS2- VASc of => 2 and HASBLED of => 2 and will undergo a valve or CABG (structural heart) procedure with direct visual access to the LAA will be eligible to participate based upon the inclusion and exclusion criteria defined in this protocol. Up to 2000 patients will enroll at up to 40 sites and will be randomized 2:1 (2 with AtriClip to 1 without AtriClip. Subjects who not develop Post-operative Atrial Fibrillation (POAF) will be followed for 30 days for safety. Subjects who develop POAF and receive the AtriClip will be followed for 365 days post index procedure.

NCT ID: NCT02029534 Recruiting - Clinical trials for Cardiothoracic Surgery

Intensive Statin Therapy Effect on Post-Operative Atrial Fibrillation (POAF)

Start date: August 2013
Phase: Phase 4
Study type: Interventional

This study will compare the effects of 20 mg of atorvastatin to 80 mg of atorvastatin for the prevention of atrial fibrillation after cardiothoracic surgery. The study hypothesis is that 80 mg of atorvastatin will be more effective at preventing atrial fibrillation compared to 20 mg.